Serum (1→3)-β-D-Glucan Measurement in Coccidioidomycosis

被引：41

作者：

Thompson, George R., III ^{[1
,2
]}

Bays, Derek J. ^{[1
]}

Johnson, Suzanne M. ^{[1
]}

Cohen, Stuart H. ^{[2
]}

Pappagianis, Demosthenes ^{[1
]}

Finkelman, Malcolm A. ^{[3
]}

机构：

[1] Univ Calif Davis, Dept Med Microbiol & Immunol, Coccidioidomycosis Serol Lab, Davis, CA 95616 USA

[2] Univ Calif Davis, Med Ctr, Dept Internal Med, Div Infect Dis, Sacramento, CA 95817 USA

[3] Associates Cape Cod Inc, E Falmouth, MA USA

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2012年 / 50卷 / 09期

关键词：

INVASIVE FUNGAL-INFECTIONS; SURVEILLANCE NETWORK TRANSNET; BETA-D-GLUCAN; TRANSPLANT RECIPIENTS; DIAGNOSIS; POSADASII; LEUKEMIA; MYCOSIS;

D O I：

10.1128/JCM.00631-12

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The serum (1 -> 3)-beta-D-glucan assay has emerged as an important diagnostic test for invasive fungal disease. The utility of this assay in coccidioidomycosis has not been previously studied. Using a cutoff value of >= 80 pg/ml, we found the sensitivity (43.9%), specificity (91.1%), positive predictive value (81.8%), and negative predictive value (64.1%) to be similar to those of the assay in diagnosing other invasive mycoses.

引用

页码：3060 / 3062

页数：3

共 50 条

[31] False positive serum levels of (1-3)-β-D-Glucan after infusion of intravenous immunoglobulins and time to normalisation
Egger, M.
Prueller, F.
Raggam, R.
Divjak, M. K.
Kurath-Koller, S.
Lackner, H.
Urban, C.
Strenger, V.
JOURNAL OF INFECTION, 2018, 76 (02) : 206 - 210
[32] (1,3)-β-D-glucan is able to predict therapeutic failure of patients with candidemia and not only mortality
Esteves, Patricia
Lopes Lima, Soraia
Salles de Azevedo Melo, Analy
Maria Beirao, Elisa
Nucci, Marcio
Colombo, Arnaldo L.
MYCOSES, 2021, 64 (03) : 264 - 271
[33] N-Terminal (1→3)-β-D-Glucan Recognition Proteins from Insects Recognize the Difference in Ultra-Structures of (1→3)-β-D-Glucan
Adachi, Yoshiyuki
Ishii, Masaki
Kanno, Takashi
Tetsui, Junko
Ishibashi, Ken-ichi
Yamanaka, Daisuke
Miura, Noriko
Ohno, Naohito
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (14)
[34] β-D-Glucan Assay in Diagnosis and Monitoring the Systemic Candidiasis in a Rat Model
Khodadadi, Hossein
Mirhendi, Hossein
Makimura, Koichi
Satoh, Kazuo
Karimi, Ladan
Izadi, Shahrokh
JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2014, 7 (06)
[35] Serum (1→3)-β-D-glucan and galactomannan levels in patients with cystic fibrosis: a retrospective cohort study
Traeger, Johannes
Melichar, Volker Otto
Meyer, Renate
Rauh, Manfred
Bogdan, Christian
Held, Juergen
BMC PULMONARY MEDICINE, 2018, 18
[36] Leaky Gut Syndrome Is Associated with Endotoxemia and Serum (1→3)-β-D-Glucan in Severe Dengue Infection
Chancharoenthana, Wiwat
Leelahavanichkul, Asada
Ariyanon, Wassawon
Vadcharavivad, Somratai
Phatcharophaswattanakul, Suphasit
Kamolratanakul, Supitcha
Leaungwutiwong, Pornsawan
Phumratanaprapin, Weerapong
Wilairatana, Polrat
MICROORGANISMS, 2021, 9 (11)
[37] Evaluation of gastrointestinal leakage using serum (1→3)-β-D-glucan in a Clostridium difficile murine model
Leelahavanichkul, Asada
Panpetch, Wimonrat
Worasilchai, Navaporn
Somparn, Poorichaya
Chancharoenthana, Wiwat
Nilgate, Sumanee
Finkelman, Malcolm
Chindamporn, Ariya
Tumwasorn, Somying
FEMS MICROBIOLOGY LETTERS, 2016, 363 (18)
[38] Serum (1 → 3)-β-D-glucan could be useful to rule out invasive candidiasis in neonates with an adapted cut-off
Cliquennois, Pauline
Scherdel, Pauline
Lavergne, Rose-Anne
Flamant, Cyril
Morio, Florent
Cohen, Jeremie F.
Launay, Elise
Le Guen, Christele Gras
ACTA PAEDIATRICA, 2021, 110 (01) : 79 - 84
[39] (1,3)-β-D-Glucan as a Prognostic Marker of Treatment Response in Invasive Candidiasis
Jaijakul, Siraya
Vazquez, Jose A.
Swanson, Robert N.
Ostrosky-Zeichner, Luis
CLINICAL INFECTIOUS DISEASES, 2012, 55 (04) : 521 - 526
[40] Diagnosis of pneumocystis pneumonia using serum (1-3)-β-D-Glucan: a bivariate meta-analysis and systematic review
Li, Wei-Jie
Guo, Ya-Ling
Liu, Tang-Juan
Wang, Ke
Kong, Jin-Liang
JOURNAL OF THORACIC DISEASE, 2015, 7 (12) : 2214 - 2225

← 1 2 3 4 5 →